Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Mark Brister > Profile

Mark Brister

Affiliations

Chief Technology Officer at Obalon Therapeutics Inc (OBLN), 2020-01-28

Insider Trading: Purchases See All

Company	Symbol	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Obalon Therapeutics Inc	OBLN	$4.00	5,000		38,865	2019-08-06	Filing